Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yonglan Liu

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Physical Chemistry. B|May 15, 2024
SHP2-EGFR States in Dephosphorylation Can Inform Selective SHP2 Inhibitors, Dampening RasGAP ActionYonglan Liu, Hyunbum Jang, Ruth Nussinov
Chemical Science|January 19, 2024
The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimizationYonglan Liu, Mingzhen Zhang, Hyunbum Jang, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|December 28, 2023
Perspectives on Theoretical Models and Molecular Simulations of Polymer BrushesYijing Tang, Yonglan Liu, Dong Zhang, et al.
Cellular and Molecular Life Sciences : CMLS|December 12, 2023
SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensitiesYonglan Liu, Wengang Zhang, Hyunbum Jang, et al.
JACS Au|May 31, 2024
CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug TargetsWengang Zhang, Yonglan Liu, Hyunbum Jang, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
mTOR variants activation discovers PI3K-like cryptic pocket, expanding allosteric, mutant-selective inhibitor designsYonglan Liu, Wengang Zhang, Hyunbum Jang, et al.
RSC Chemical Biology|November 3, 2023
Protein conformational ensembles in function: roles and mechanismsRuth Nussinov, Yonglan Liu, Wengang Zhang, et al.
Current Opinion in Structural Biology|October 23, 2023
Cell phenotypes can be predicted from propensities of protein conformationsRuth Nussinov, Yonglan Liu, Wengang Zhang, et al.
Drug Discovery Today|March 12, 2023
AlphaFold, allosteric, and orthosteric drug discovery: Ways forwardRuth Nussinov, Mingzhen Zhang, Yonglan Liu, et al.
Journal of Chemical Information and Modeling|January 10, 2025
mTOR Variants Activation Discovers PI3K-like Cryptic Pocket, Expanding Allosteric, Mutant-Selective Inhibitor DesignsYonglan Liu, Wengang Zhang, Hyunbum Jang, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Physical Chemistry. B|May 15, 2024
SHP2-EGFR States in Dephosphorylation Can Inform Selective SHP2 Inhibitors, Dampening RasGAP ActionYonglan Liu, Hyunbum Jang, Ruth Nussinov
Chemical Science|January 19, 2024
The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimizationYonglan Liu, Mingzhen Zhang, Hyunbum Jang, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|December 28, 2023
Perspectives on Theoretical Models and Molecular Simulations of Polymer BrushesYijing Tang, Yonglan Liu, Dong Zhang, et al.
Cellular and Molecular Life Sciences : CMLS|December 12, 2023
SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensitiesYonglan Liu, Wengang Zhang, Hyunbum Jang, et al.
JACS Au|May 31, 2024
CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug TargetsWengang Zhang, Yonglan Liu, Hyunbum Jang, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
mTOR variants activation discovers PI3K-like cryptic pocket, expanding allosteric, mutant-selective inhibitor designsYonglan Liu, Wengang Zhang, Hyunbum Jang, et al.
RSC Chemical Biology|November 3, 2023
Protein conformational ensembles in function: roles and mechanismsRuth Nussinov, Yonglan Liu, Wengang Zhang, et al.
Current Opinion in Structural Biology|October 23, 2023
Cell phenotypes can be predicted from propensities of protein conformationsRuth Nussinov, Yonglan Liu, Wengang Zhang, et al.
Drug Discovery Today|March 12, 2023
AlphaFold, allosteric, and orthosteric drug discovery: Ways forwardRuth Nussinov, Mingzhen Zhang, Yonglan Liu, et al.
Journal of Chemical Information and Modeling|January 10, 2025
mTOR Variants Activation Discovers PI3K-like Cryptic Pocket, Expanding Allosteric, Mutant-Selective Inhibitor DesignsYonglan Liu, Wengang Zhang, Hyunbum Jang, et al.
Pageof 8